Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anavex Lf SC (AVXL)

Anavex Lf SC (AVXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,027,122
  • Shares Outstanding, K 84,816
  • Annual Sales, $ 0 K
  • Annual Income, $ -47,510 K
  • EBIT $ -51 M
  • EBITDA $ -51 M
  • 60-Month Beta 0.73
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.86

Options Overview Details

View History
  • Implied Volatility 120.06% ( -1.08%)
  • Historical Volatility 119.45%
  • IV Percentile 72%
  • IV Rank 27.17%
  • IV High 388.12% on 04/04/24
  • IV Low 20.06% on 05/01/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 3,263
  • Volume Avg (30-Day) 3,753
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 73,760
  • Open Int (30-Day) 69,516

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.17
  • Number of Estimates 1
  • High Estimate -0.17
  • Low Estimate -0.17
  • Prior Year -0.11
  • Growth Rate Est. (year over year) -54.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.59 +59.55%
on 12/05/24
14.44 -16.14%
on 12/26/24
+3.08 (+34.11%)
since 11/27/24
3-Month
5.03 +140.76%
on 10/10/24
14.44 -16.14%
on 12/26/24
+6.43 (+113.20%)
since 09/27/24
52-Week
3.25 +272.62%
on 04/25/24
14.44 -16.14%
on 12/26/24
+2.20 (+22.20%)
since 12/27/23

Most Recent Stories

More News
Short-Squeeze Target Anavex Life Sciences Gains Traction

Anavex Life Sciences stock market is set up for a short squeeze that could begin in early 2025 and increase the price by 400% or more.

AVXL : 12.11 (-3.58%)
Anavex Sciences Soars On Earnings Relief, EU Filing Acceptance For Alzheimer’s Drug: Retail’s Overjoyed

The broader market’s interest in Alzheimer’s therapies remains intense, particularly after Cassava Sciences reported disappointing results for its candidate simufilam last month.

AVXL : 12.11 (-3.58%)
SAVA : 2.50 (-3.47%)
Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

AVXL : 12.11 (-3.58%)
Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

AVXL : 12.11 (-3.58%)
Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease

AVXL : 12.11 (-3.58%)
Anavex Life Sciences Corp. to Announce Fiscal Year 2024 Financial Results on December 23, 2024

Anavex Life Sciences Corp. will announce fiscal year results on December 23, 2024, with a conference call to follow.Quiver AI SummaryAnavex Life Sciences Corp. announced that it will release its financial...

AVXL : 12.11 (-3.58%)
Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024

AVXL : 12.11 (-3.58%)
Anavex Life Sciences to Present Long-Term Data from Phase IIb/III ATTENTION-AD Trial at J.P. Morgan 2025 Healthcare Conference

Anavex will present long-term ATTENTION-AD trial data at the J.P. Morgan 2025 Healthcare Conference in January.Quiver AI SummaryAnavex Life Sciences Corp. is set to present topline long-term data from...

AVXL : 12.11 (-3.58%)
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference

AVXL : 12.11 (-3.58%)
Anavex Life Sciences Corp. CEO to Participate in Fireside Chat at Evercore ISI HealthCONx Conference 2024

Anavex Life Sciences CEO to discuss company advancements at Evercore ISI HealthCONx Conference on December 4, 2024.Quiver AI SummaryAnavex Life Sciences Corp., a biopharmaceutical company focused on developing...

AVXL : 12.11 (-3.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill...

See More

Key Turning Points

3rd Resistance Point 14.58
2nd Resistance Point 13.94
1st Resistance Point 13.03
Last Price 12.11
1st Support Level 11.48
2nd Support Level 10.84
3rd Support Level 9.93

See More

52-Week High 14.44
Last Price 12.11
Fibonacci 61.8% 10.17
Fibonacci 50% 8.85
Fibonacci 38.2% 7.52
52-Week Low 3.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar